Heart Attack Diagnostics Market

Heart Attack Diagnostics Market Size By Test (Electrocardiogram, Angiogram, Blood Tests, Computerized Cardiac Tomography, and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13522
  • Published Date: Jun, 2023
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global heart attack diagnostics market was valued at USD 9.5 billion in 2022 and growing at a CAGR of 8% from 2023 to 2032. The market is expected to reach USD 20.5 billion by 2032. The high prevalence of CAD, the rising elderly population, obesity in people who smoke, and the adoption of unhealthful diets that increase the incidence of high cholesterol are the main factors affecting the market's growth.

Market Introduction:

Myocardial ischemia, often known as a heart attack or myocardial infarction, is a type of cardiovascular disease (CVD) that affects the heart muscle and reduces or decreases oxygen-rich blood flow. It has an unacceptably high burden and risk factor and is one of the main causes of death worldwide. Myocardial infarctions must be treated right away due to their urgent nature. Adopting unhealthy lifestyle habits, such as poor diets, is the leading risk factor for heart attacks. Other risk factors include smoking, having a high body mass index, being sedentary, and having a high prevalence of chronic diseases like diabetes and hypertension. Due to the deposition or accumulation of fat, cholesterol, and other chemicals due to these risk factors, the coronary arteries that supply the heart become narrowed, causing atherosclerosis or Coronary Artery Disease (CAD). According to a study, a heart attack strikes a U.S. citizen once every 43 seconds.

Heart Attack Diagnostics Market Size

Get an overview of this study by requesting a free sample

Recent Development

In April 2021, A series of five new intended uses for two important cardiac biomarkers—highly sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP)—using Elecsys® technology was introduced by Roche.

In March 2021, the European Union approved CaRi-Heart Technology, which uses artificial intelligence to identify and predict the risk of a severe heart attack years in advance. The British Heart Foundation and Caristo Diagnostics created the CaRi-Heart Technology.

In January 2021, Epi+Gen CHD was introduced by Cardio Diagnostics in conjunction with MOgene, LC, and InTeleLabs (felicity). The epigenetic-based, at-home clinical test Epi+Gen CHD redefines the prevention of coronary heart disease, the most common form of the disease and the primary cause of heart attacks.

In September 2021, the pharmaceuticals business AstraZeneca India introduced 'Project Heart Beat' in association with the Bengaluru-based startup Tricog.

In April 2021, Roche announced a series of five new intended uses for the N-terminal pro-brain natriuretic peptide test (NT-proBNP) and high-sensitivity cardiac troponin T (cTnT-hs), two crucial cardiac biomarkers.

Market Dynamics:

Drivers

Rising Prevalence of CDVs- The prevalence of cardiovascular disease is a complex issue driven by various factors, such as dietary practices, environmental exposures, and genetic predisposition. These factors can result in high blood pressure, high cholesterol, obesity, and diabetes, raising the risk of cardiovascular disease. For instance, according to WHO 2021, cardiovascular diseases (CVDs) are the most significant cause of death globally, accounting for 17.9 million deaths annually. The group of heart and blood vessel disorders known as CVDs includes conditions like coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses. Heart attacks and strokes cause more than four out of every five CVD deaths, and a third occur before age 70.

Restraints:

Lack of Skilled Workers- The need for more competent workers in the healthcare industry is a significant barrier to the growth of the heart attack diagnostics market. For instance, the WHO predicts that there will be a shortage of 13 million medical professionals worldwide by 2030. The lack of medical experts certified to utilize medical equipment and conduct diagnostic tests is predicted to reduce the market demand for such items.

Opportunities:

Rising R&D- Strategically, vendors are concentrating on creating and promptly approving new heart attack diagnostic tools. The vendors can maintain their position in the competitive heart attack diagnostics market and grow by combining new product development with R&D operations. Electrocardiogram (ECG) machines and Troponin for better visualization are two examples of revolutionary gadgets that vendors are actively interested in developing to improve the clinical outcomes of heart attack diagnostic technologies. Vendors are also actively engaged in R&D efforts and have unique items planned for release in the upcoming years. They are working on creating cutting-edge 3D mammography technology.

Challenges:

Rising Competition- Key international and local/regional producers compete fiercely for the global heart attack diagnostics market. Several international businesses dominate the market, although a few regional players compete there. Local manufacturers and sellers can produce and market their goods for a lot less money than multinational companies like Abbott, F. Hoffmann-La Roche AG, and Siemens Healthcare. The lower pricing strategy also puts top players under pressure to reevaluate their pricing strategy in the current market environment. The leading players adapt tactics to get a competitive advantage over other top and local/regional players.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global heart attack diagnostics market, with a 44% share of the market revenue in 2022.

The US Centres for Disease Control (CDC) found that every 40 seconds, an American may have a heart attack. Heart attacks are one of the most expensive hospital conditions in the U.S. According to the American Heart Association, 47% of Americans are expected to develop heart disease by 2035. This is due to factors like widespread obesity, smoking, and unhealthy lifestyle choices, which can lead to heart attacks and other problems of a similar nature. The essential players' Product introductions and approvals aid in dominating the area. For instance, Cardio Diagnostics Holdings, a company that employs artificial intelligence to promote precision cardiovascular care, announced the release of PrecisionCHD in February 2023. PrecisionCHD is an integrated epigenetic-genetic blood test for the early identification of coronary heart disease.

North America Region Heart Attack Diagnostics Market Share in 2022 - 44%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Abbott Laboratories is a publicly traded business with its headquarters in the U.S. It is a multinational corporation with revenues of $43,075 million and around 113,000 employees. Along with its other products, it generates money from the global heart attack diagnostics market, although it is not the company's primary source of income.
Test Segment Analysis

The test segment is divided into electrocardiogram, angiogram, blood tests, computerized cardiac tomography, and others. The electrocardiogram segment dominated the market, with a market share of around 39% in 2022. Several factors are expected to contribute to the segment's growth, including an increase in the number of patients with chronic heart failure, rising demand for advanced cardiovascular treatment as a result of increased tobacco use, obesity, coronary heart disease, and the adoption of a bad diet that raises cholesterol levels. For instance, H.F. diagnoses in the U.S. cause more than one million hospital admissions and more than 300,000 mortality annually. Spending on healthcare is expected to reach USD 70 billion by 2030. Due to the increasing number of cases of chronic heart failure, there has been an increase in demand for the ECG, which is expected to command the largest market share during the forecast period.

Some of the Key Market Players:
  • F Hoffmann-La Roche Ltd
  • Hitachi Medical Systems
  • GE Healthcare
  • Schiller AG
  • Siemens Healthineers
  • HeartFlow
  • Beckman Coulter
  • Medtronic
  • Cardio Diagnostics Holdings Inc
  • Midmark Corporation

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 9.5 Billion
Market size value in 2032 USD 20.5 Billion
CAGR (2023 to 2032) 8%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Test

Frequesntly Asked Questions

As per The Brainy Insights, the size of the heart attack diagnostics market was valued at USD 9.5 billion in 2022 to USD 20.5 billion by 2032.

The global heart attack diagnostics market is growing at a CAGR of 8% during the forecast period 2023-2032.

North America emerged as the largest heart attack diagnostics market.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Test
          4.3.2. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising prevalence of CDVs
    5.3. Restraints
          5.3.1. Lack of skilled workers
    5.4. Opportunities
          5.4.1. Rising R&D
    5.5. Challenges
          5.5.1. Rising Competition

6. Global Heart Attack Diagnostics Market Analysis and Forecast, By Test
    6.1. Segment Overview
    6.2. Electrocardiogram
    6.3. Angiogram
    6.4. Blood Tests
    6.5. Computerized Cardiac Tomography
    6.6. Others

7. Global Heart Attack Diagnostics Market Analysis and Forecast, By Regional Analysis
    7.1. Segment Overview
    7.2. North America
          7.2.1. U.S.
          7.2.2. Canada
          7.2.3. Mexico
    7.3. Europe
          7.3.1. Germany
          7.3.2. France
          7.3.3. U.K.
          7.3.4. Italy
          7.3.5. Spain
    7.4. Asia-Pacific
          7.4.1. Japan
          7.4.2. China
          7.4.3. India
    7.5. South America
          7.5.1. Brazil
    7.6. Middle East and Africa
          7.6.1. UAE
          7.6.2. South Africa

8. Global Heart Attack Diagnostics Market-Competitive Landscape
    8.1. Overview
    8.2. Market Share of Key Players in Global Heart Attack Diagnostics Market
          8.2.1. Global Company Market Share
          8.2.2. North America Company Market Share
          8.2.3. Europe Company Market Share
          8.2.4. APAC Company Market Share
    8.3. Competitive Situations and Trends
          8.3.1. Product Launches and Developments
          8.3.2. Partnerships, Collaborations, and Agreements
          8.3.3. Mergers & Acquisitions
          8.3.4. Expansions

9. Company Profiles
    9.1. F Hoffmann-La Roche Ltd
          9.1.1. Business Overview
          9.1.2. Company Snapshot
          9.1.3. Company Market Share Analysis
          9.1.4. Company Product Portfolio
          9.1.5. Recent Developments
          9.1.6. SWOT Analysis
    9.2. Hitachi Medical Systems
          9.2.1. Business Overview
          9.2.2. Company Snapshot
          9.2.3. Company Market Share Analysis
          9.2.4. Company Product Portfolio
          9.2.5. Recent Developments
          9.2.6. SWOT Analysis
    9.3. GE Healthcare
          9.3.1. Business Overview
          9.3.2. Company Snapshot
          9.3.3. Company Market Share Analysis
          9.3.4. Company Product Portfolio
          9.3.5. Recent Developments
          9.3.6. SWOT Analysis
    9.4. Schiller AG
          9.4.1. Business Overview
          9.4.2. Company Snapshot
          9.4.3. Company Market Share Analysis
          9.4.4. Company Product Portfolio
          9.4.5. Recent Developments
          9.4.6. SWOT Analysis
    9.5. Siemens Healthineers
          9.5.1. Business Overview
          9.5.2. Company Snapshot
          9.5.3. Company Market Share Analysis
          9.5.4. Company Product Portfolio
          9.5.5. Recent Developments
          9.5.6. SWOT Analysis
    9.6. HeartFlow
          9.6.1. Business Overview
          9.6.2. Company Snapshot
          9.6.3. Company Market Share Analysis
          9.6.4. Company Product Portfolio
          9.6.5. Recent Developments
          9.6.6. SWOT Analysis
    9.7. Beckman Coulter
          9.7.1. Business Overview
          9.7.2. Company Snapshot
          9.7.3. Company Market Share Analysis
          9.7.4. Company Product Portfolio
          9.7.5. Recent Developments
          9.7.6. SWOT Analysis
    9.8. Medtronic
          9.8.1. Business Overview
          9.8.2. Company Snapshot
          9.8.3. Company Market Share Analysis
          9.8.4. Company Product Portfolio
          9.8.5. Recent Developments
          9.8.6. SWOT Analysis
    9.9. Cardio Diagnostics Holdings Inc
          9.9.1. Business Overview
          9.9.2. Company Snapshot
          9.9.3. Company Market Share Analysis
          9.9.4. Company Product Portfolio
          9.9.5. Recent Developments
          9.9.6. SWOT Analysis
    9.10. Midmark Corporation
          9.10.1. Business Overview
          9.10.2. Company Snapshot
          9.10.3. Company Market Share Analysis
          9.10.4. Company Product Portfolio
          9.10.5. Recent Developments
          9.10.6. SWOT Analysis

List of Table

1. Global Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

2. Global Electrocardiogram, Heart Attack Diagnostics Market, By Region, 2019-2032 (USD Billion) 

3. Global Angiogram, Heart Attack Diagnostics Market, By Region, 2019-2032 (USD Billion) 

4. Global Blood Tests, Heart Attack Diagnostics Market, By Region, 2019-2032 (USD Billion) 

5. Global Computerized Cardiac Tomography, Heart Attack Diagnostics Market, By Region, 2019-2032 (USD Billion)

6. Global Others, Heart Attack Diagnostics Market, By Region, 2019-2032 (USD Billion)

7. North America Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

8. U.S. Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

9. Canada Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

10. Mexico Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

11. Europe Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

12. Germany Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

13. France Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

14. U.K. Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

15. Italy Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

16. Spain Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

17. Asia Pacific Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

18. Japan Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

19. China Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

20. India Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

21. South America Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

22. Brazil Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

23. Middle East and Africa Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

24. UAE Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

25. South Africa Heart Attack Diagnostics Market, By Test, 2019-2032 (USD Billion)

List of Figures 

1. Global Heart Attack Diagnostics Market Segmentation

2. Global Heart Attack Diagnostics Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Heart Attack Diagnostics Market Attractiveness Analysis by Test

9. Global Heart Attack Diagnostics Market Attractiveness Analysis by Region

10. Global Heart Attack Diagnostics Market: Dynamics

11. Global Heart Attack Diagnostics Market Share by Test (2023 & 2032)

12. Global Heart Attack Diagnostics Market Share by Regions (2023 & 2032)

13. Global Heart Attack Diagnostics Market Share by Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global heart attack diagnostics market based on the below-mentioned segments:

Global Heart Attack Diagnostics Market By Test:

  • Electrocardiogram
  • Angiogram
  • Blood Tests
  • Computerized Cardiac Tomography
  • Others

Global Heart Attack Diagnostics Market By Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date